Metropolis Healthcare Limited — Others, 10-01-2025: Shareholders meeting

Metropolis Healthcare Limited has announced a board meeting to discuss a Postal Ballot seeking shareholder approval for a preferential issue of equity shares. The plan involves issuing up to 5,18,920 shares at INR 2,140.54 per share, aimed at financing a portion of the INR 246.84 crore acquisition of Core Diagnostics. The e-voting period will run from January 11 to February 9, 2025, with results announced by February 11, 2025. This acquisition is expected to enhance Metropolis’s oncology testing capabilities, expanding its market presence and driving future growth.

Investors may view this as a positive outlook given the strategic acquisition in a fast-growing segment.